Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,013.8
-0.9 (-0.03%)

 

  • STI Straits Times Index
    3,013.8
    -0.9 (-0.03%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,600.1
    18.9 (1.19%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,098.3
    -138.5 (-0.47%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,502.0
    -1.5 (-0.04%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,864.3
    -65.8 (-0.23%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,258.7
    -32.1 (-0.51%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,088.5M
  • Value: 1,589.7M
  • Rise: 159
  • Fall: 161
  • Unch: 454

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
FJ Benjamin0.044+0.001
Oceanus^0.043-
HGH0.012-0.002
Sembcorp Marine0.157-
CWX Global0.005+0.001
Thomson Medical0.108+0.002
Arion Ent0.017-0.005
ICP Ltd0.012+0.002
Shen Yao0.004+0.001
Jasper Inv0.005-

World Indices

World Indices
Name Last Change
Nasdaq 12,723.5 -274.3
HSI 29,098.3 -138.5
HSCEI 11,292.2 -33.4
Jakarta 6,258.7 -32.0
Nikkei 225 28,864.3 -65.8
SSE Comp 3,502.0 -1.5
Shanghai A 3,670.8 -1.6
Shanghai B 244.9 -1.1
KOSPI 3,026.3 -17.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ALTERITY THERAPEUTICS LIMITED ALTERITY THERAPEUTICS LIMITED
Updated on 05 Mar 2021 (End of trading day)
Last (AUD): 0.030 Change: -0.003 High: 0.033 Remarks: -
Change (%): -9.09 Low: 0.030
Open 0.033 Yesterday's Close 0.033
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 23,768,300 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.00646 Trailing EPS (AUD) e -0.00786 NAV (AUD) b 0.0165
PE a - Trailing PE f - Price / NAV b 1.8182
Dividend (AUD) d - Cash In Hand (AUD) g 0.0168 Issued & Paid-up Shares c 2,084,020,000
Dividend Yield (%) d - Price / Cash In Hand g 1.786 Treasury Shares h -
Beta - 75 Daysi -0.811 R-Squared - 75 Days(%)i 0.77 Market Cap (M) 62.521
Beta - 500 Daysi -0.377 R-Squared - 500 Days (%)i 0.30 Enterprise Value (M) 27.479
Piotroski F Score 0 Exchange Code ATH Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 151.22 Free Float (%) 81.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 Feb 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 12 Apr 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ALTERITY THERAPEUTICS LIMITED ASX 62.521 - - 1.8182 -
Industry Biotechnology ASX 3,180.022 44.297 36.391 10.2967 1.077
Local Peer CSL LTD ASX 113,106.883 36.064 29.720 10.7034 1.181
Local Peer POLYNOVO LIMITED ASX 1,587.331 - - 72.0721 -
Local Peer MESOBLAST LTD ASX 1,445.266 - - 1.9237 -
Local Peer TELIX PHARMACEUTIC ASX 1,042.343 - - 13.1935 -
Local Peer OPTHEA LIMITED ASX 506.496 - - 2.5632 -
Local Peer IMUGENE LIMITED ASX 456.922 - - 7.2727 -
Local Peer ANTEOTECH LIMITED ASX 337.273 - - 54.5455 -
Local Peer BIONOMICS LTD ASX 240.977 - - 15.0000 -
Local Peer NEXT SCIENCE LTD ASX 236.925 - - 9.6672 -
Local Peer IMMUTEP LTD ASX 201.105 - - - -
Local Peer KAZIA THERAPEUTICS LIMITED ASX 161.994 - - 5.1139 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 147.010 - - 6.0739 -
Other Local Peers LEAF RESOURCES LTD (ASX), GENETIC TECHNOLOGIES (ASX), CHIMERIC THERAPEUTICS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), MEMPHASYS LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), BIOTRON (ASX), PATRYS LIMITED (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), ADALTA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), REGENEUS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), RHINOMED LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), NANOLLOSE LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 128,167.671 17.644 17.644 13.6218 2.888
Global Peer GILEAD SCIENCES INC NASDAQ 79,454.186 645.995 645.969 4.3651 4.293
Global Peer ILLUMINA INC NASDAQ 58,303.099 88.877 88.877 12.4208 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 54,017.088 19.920 19.920 6.2183 -
Global Peer MODERNA INC NASDAQ 52,889.571 - - 20.6490 -
Global Peer WUXI BIO HKEx 376,808.425 327.779 261.689 25.2248 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 48,142.965 13.703 13.703 4.3666 -
Global Peer BIOGEN INC NASDAQ 40,151.200 10.036 10.036 3.7523 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 32,638.634 54.091 54.091 2.8013 -
Global Peer 10X GENOMICS INC NASDAQ 25,334.463 - - 34.2791 -
Other Global Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), SEAGEN INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SINO BIOPHARM (HKEx), ALNYLAM PHARMACEUTICALS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), BIO-TECHNE CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), ZAI LAB-SB (HKEx), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ACCELERON PHARMA (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), JOINN (HKEx), ALLOGENE THERAPEUTICS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), ARVINAS INC (NASDAQ), VERACYTE INC (NASDAQ), GENSCRIPT BIO (HKEx), RELAY THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), SEER INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ALKERMES PLC (NASDAQ), VIELA BIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), NANTKWEST INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), LIGAND PHARMACEUTICAL INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), ALLOVIR INC (NASDAQ), NUVATION BIO INC (NYSE), BIONANO GENOMICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), OCUGEN INC (NASDAQ), JACOBIO-B (HKEx), AURINIA PHARMACEUTICALS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), JW THERAP-B (HKEx), ZENTALIS PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), REGENXBIO INC (NASDAQ), PRECIGEN INC (NASDAQ), BIOATLA INC (NASDAQ), ALPHAMAB-B (HKEx), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), TRANSLATE BIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), VIVA BIOTECH (HKEx), UNIQURE N.V. (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), NKARTA INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOVANT INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), VAXCYTE INC (NASDAQ), ALECTOR INC (NASDAQ), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), RHYTHM PHARMACEUTICALS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), OMEROS CORP (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), JHBP-B (HKEx), BIOXCEL THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ASCENTAGE-B (HKEx), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), INHIBRX INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), CORTEXYME INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VANDA PHARMACE INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), RADIUS HEALTH INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CHIMERIX INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MERUS B V (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), HUMANIGEN INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), KINTOR PHARMA-B (HKEx), CURIS INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), KADMON HLDGS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), VAXART INC (NASDAQ), COMPUGEN (NASDAQ), VBI VACCINES INC CDA (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), AKOUOS INC (NASDAQ), IMMATICS N V (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), ATRECA INC (NASDAQ), AFFIMED N V (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), AGENUS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), MAGENTA THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), IVERIC BIO INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ALTIMMUNE INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), SINOMAB BIO-B (HKEx), AKEBIA THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), DPHARMA (Bursa), SPECTRUM PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ADICET BIO INC (NASDAQ), ESSEX BIO-TECH (HKEx), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), AVROBIO INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), ASCLETIS-B (HKEx), RAPT THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), LEE'S PHARM (HKEx), SESEN BIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), XOMA CORP (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), VERASTEM INC (NASDAQ), ONCORUS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), IMMUNOME INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), APTOSE BIOSCIENCES INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), VISTAGEN THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), BIOVIE INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), NEXTCURE INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), KAMADA LTD (NASDAQ), CABALETTA BIO INC (NASDAQ), MEDICINOVA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), INMUNE BIO INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), METACRINE INC (NASDAQ), IMV INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CHIASMA INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), EQUILLIUM INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), EVOGENE LTD (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), BIOMX INC (NYSE American), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CEL-SCI CORP (NYSE American), HARVARD BIOSCIENCE INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), LONGEVERON INC (NASDAQ), IBIO INC (NYSE American), GLYCOMIMETICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ENZO BIOCHEM INC (NYSE), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SYNLOGIC INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ARAVIVE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), OTONOMY INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), CAPRICOR THERAPEUTICS INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), SAVARA INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), COHBAR INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ADVAXIS INC (NASDAQ), UNI-BIO GROUP (HKEx), ORGANOVO HLDGS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), MONOPAR THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), REGENT PACIFIC (HKEx), AZURRX BIOPHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), BIOCARDIA INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), KIROMIC BIOPHARMA INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ORAGENICS INC (NYSE American), ATYR PHARMA INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), PRECIPIO INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), Suntar Eco-City (SGX), INMED PHARMACEUTICALS INC (NASDAQ), HISTOGEN INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), SENESTECH INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.008
-21.05 %
10 Days --0.010
-25.00 %
20 Days --0.010
-25.00 %
Medium Term Return 3 Months --0.002
-6.25 %
6 Months --0.019
-38.78 %
1 Year -+0.017
+130.77 %
Long Term Return 2 Years --0.170
-85.00 %
3 Years --0.170
-85.00 %
5 Years --0.170
-85.00 %
Annualised Return Annualised --
-31.57 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.012 - 0.410 Change From 1 Year Low +0.018 % Change From 1 Year Low (%) +150.00
Change From 1 Year High -0.380 % Change From 1 Year High (%) -92.68
2 Years Range 0.012 - 0.410 Change From 2 Years Low +0.018 % Change From 2 Years Low (%) +150.00
Change From 2 Years High -0.380 % Change From 2 Years High (%) -92.68
5 Years Range 0.012 - 0.410 Change From 5 Years Low +0.018 % Change From 5 Years Low (%) +150.00
Change From 5 Years High -0.380 % Change From 5 Years High (%) -92.68
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. It focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
05 Mar 2021 0.033 0.033 0.030 0.030 23,768,300 -
04 Mar 2021 0.034 0.034 0.033 0.033 2,855,066 -
03 Mar 2021 0.035 0.036 0.034 0.034 14,464,150 -
02 Mar 2021 0.036 0.037 0.035 0.035 5,475,957 -
01 Mar 2021 0.037 0.037 0.036 0.036 5,632,563 -
26 Feb 2021 0.038 0.038 0.037 0.038 6,325,411 -
25 Feb 2021 0.040 0.040 0.038 0.039 4,405,947 -
24 Feb 2021 0.040 0.040 0.038 0.038 13,433,170 -
23 Feb 2021 0.040 0.042 0.039 0.040 8,757,624 -
22 Feb 2021 0.041 0.042 0.040 0.040 8,198,137 -
19 Feb 2021 0.041 0.043 0.040 0.040 9,739,144 -
18 Feb 2021 0.044 0.044 0.041 0.041 8,859,005 -
17 Feb 2021 0.044 0.045 0.043 0.043 7,105,180 -
16 Feb 2021 0.044 0.045 0.042 0.043 13,409,250 -
15 Feb 2021 0.042 0.046 0.042 0.045 36,434,430 -
12 Feb 2021 0.041 0.043 0.040 0.042 8,329,252 -
11 Feb 2021 0.041 0.043 0.037 0.041 29,723,970 -
10 Feb 2021 0.045 0.045 0.041 0.042 49,530,580 -
09 Feb 2021 0.048 0.053 0.045 0.048 167,139,600 -
08 Feb 2021 0.041 0.041 0.038 0.039 5,360,740 -
05 Feb 2021 0.039 0.041 0.039 0.040 14,439,300 -
04 Feb 2021 0.040 0.043 0.038 0.040 49,414,230 -
Summary
Current 2 Weeks
(22 Feb 2021 to 05 Mar 2021)
0.041 0.042 0.030 0.030 93,316,325 -
Previous 2 Weeks
(08 Feb 2021 to 19 Feb 2021)
0.041 0.042 0.030 0.040 335,631,151 -
4 Weeks from
(08 Jan 2021 to 05 Feb 2021)
0.033 0.042 0.030 0.040 315,313,532 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.